Sorbic Acid

Sorbic Acid

SCHEMBL221488

C/C=C/C=C/C(=O)[O-].[Ag+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sorbic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sorbic Acid SCHEMBL221489 1.00
Sorbic Acid SCHEMBL11578741 0.97 BBOX1 (0.37)
Sorbic Acid SCHEMBL562945 0.97 BBOX1 (0.37)
Sorbic Acid SCHEMBL11578745 0.97 BBOX1 (0.37)
Sorbic Acid SCHEMBL146360 0.94 BBOX1 (0.36)
Sorbic Acid SCHEMBL146359 0.94 BBOX1 (0.36)
Sorbic Acid SCHEMBL3122853 0.94 BBOX1 (0.36)
Sorbic Acid SCHEMBL1766256 0.94 BBOX1 (0.36)
Sorbic Acid SCHEMBL3122871 0.94 BBOX1 (0.36)
Sorbic Acid SCHEMBL2485339 0.94 BBOX1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118800498-A Conductive silver paste for flexible circuit and preparation method thereof 东南大学 2024-10-18 CN claimed
EP-1567101-A4 PROPHYLACTIC TREATMENT METHODS NUCRYST PHARM CORP (CA) 2009-06-03 EP claimed
EP-1575552-A2 METAL-CONTAINING MATERIALS, COMPOSITIONS AND METHODS Nucryst Pharmaceuticals Corp. (CA) 2005-09-21 EP claimed
EP-1567101-A2 PROPHYLACTIC TREATMENT METHODS NUCFRYST PHARMACEUTICALS CORP. (CA) 2005-08-31 EP claimed
US-20040191329-A1 Compositions and methods of metal-containing materials NUCRYST PHARMACEUTICALS CORP. (CA) 2004-09-30 US claimed
US-20040110738-A1 Prophylactic treatment methods NUCRYST PHARMACEUTICALS CORP. (CA) 2004-06-10 US claimed
WO-2004037187-A2 METAL-CONTAINING MATERIALS, COMPOSITIONS AND METHODS NUCRYST PHARMACEUTICALS CORP. (CA) 2004-05-06 WO claimed
WO-2004037186-A2 PROPHYLACTIC TREATMENT METHODS NUCRYST PHARMACEUTICALS CORP. (CA) 2004-05-06 WO claimed
WO-2024258867-A1 SYSTEM AND METHOD FOR PRESERVING ALGAE Macro Oceans Inc. (US) 2024-12-19 WO disclosed
US-20240409878-A1 SYSTEM AND METHOD FOR PRESERVING ALGAE Macro Oceans Inc. (US) 2024-12-12 US disclosed
EP-2991658-B1 ANTIMICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME MEDICAL TECH RESEARCH INC (US) 2021-11-17 EP disclosed
US-11013730-B1 Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith THIOREDOXIN SYSTEMS AB (SE) 2021-05-25 US disclosed
US-20190282585-A1 ANTIMICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME MEDICAL TECHNOLOGY RESEARCH INC 2019-09-19 US disclosed
US-10350219-B2 Antimicrobial compositions and methods of making the same MEDICAL TECHNOLOGY RESEARCH INC (US) 2019-07-16 US disclosed
US-20040110738-A1 Prophylactic treatment methods NUCRYST PHARMACEUTICALS CORP. (CA) 2004-06-10 US disclosed
WO-2004037187-A2 METAL-CONTAINING MATERIALS, COMPOSITIONS AND METHODS NUCRYST PHARMACEUTICALS CORP. (CA) 2004-05-06 WO disclosed
WO-2004037186-A2 PROPHYLACTIC TREATMENT METHODS NUCRYST PHARMACEUTICALS CORP. (CA) 2004-05-06 WO disclosed
US-4188212-A BEZNOTRIAZOLE FUJI PHOTO FILM CO., LTD. (JP) 1980-02-12 US disclosed
US-4188274-A DECARBOXYLATION STANDARD OIL COMPANY (INDIANA) (US) 1980-02-12 US disclosed
US-4174447-A SILVER SALTS OF CARBOXY ACIDS STANDARD OIL COMPANY (INDIANA) (US) 1979-11-13 US disclosed